| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 415,334 | | Cost of Revenue | 183,597 | | | Gross Profit | 231,737 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 28,866 | | Non Recurring | 1,195 | | Others | 656 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 201,020 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,854 | | Earnings Before Interest And Taxes | 207,874 | | Interest Expense | 5,616 | | Income Before Tax | 202,258 | | Income Tax Expense | 59,588 | | Minority Interest |
-
| | | | Net Income From Continuing Ops | 142,670 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 142,670 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $142,670 |
|
0.34% Nasdaq 
0.54 (1.74%) 
Income Statement
